Anti-Human Tenascin X Antibody [A375]
Anti-Human Tenascin X Antibody [A375] with collaborator-tested evidence for IHC. Read more ›
![Anti-Human Tenascin X Antibody [A375]](http://www.abmium.com/cdn/shop/files/J5HZLVc7.jpg?v=1781092398&width=900)
![Anti-Human Tenascin X Antibody [A375]](http://www.abmium.com/cdn/shop/files/J5HZLVc7.jpg?v=1781092398&width=160)
["IHC"]Product Description
Tenascin X is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Monoclonal; clone: A375; isotype: IgG, κ; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for IHC. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant human Tenascin X fragment; purification: Protein A purified; concentration: 1 mg/mL.
Database references: UniProt: P22105.
Research Use Only.
Key Facts
| Target | Tenascin X |
| Also known as | VUR, EDS, TNXB, EDS3, HXBL, TENX, TN-X, TNX, TNXB1, TNXB2, TNXBS, VUR8, XB, XBS, EDSCLL, EDSCLL1, Ehlers Danlos like syndrome, Growth inhibiting protein 45, Hexabrachion like protein, Hexabrachion-like protein, NXB2, Tenascin X precursor, tenascin XB, Tenascin XB1, Tenascin XB2, Tenascin-X, TN X |
| Concentration | 1 mg/mL |
| Species reactivity | Human |
| Shelf life | 12 months from shipping dates |
| Research area | Signal Transduction |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | IHC | |
|---|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.